Registry Data you can trust: 45% data quality uplift with CompanyData.com. Get a Data Sample

List of Astellas Pharma subsidiaries

Verified insights into Astellas Pharma’s global corporate structure and subsidiaries.

Astellas Pharma Inc. is a multinational pharmaceutical company headquartered in Tokyo, Japan. Established in 2005 through a merger, Astellas operates a broad and diverse corporate network globally. Although the company has a focused portfolio, its presence extends across multiple countries to support pharmaceutical development and distribution. This ownership data is part of CompanyData.com’s verified corporate hierarchy database, covering millions of companies worldwide.

Global reach of Astellas Pharma’s subsidiaries

Astellas Pharma maintains a presence in key pharmaceutical markets. While detailed subsidiary numbers are not publicly disclosed here, their operations span important regions such as the United States, Europe, and Japan, reflecting their integrated approach to research, development, and commercialization in healthcare and pharmaceuticals.

  • Global ownership data

  • Download subsidiary lists

  • Structured hierarchies

  • Contact and email data

Top Subsidiaries and Companies Owned by Astellas Pharma

No data available

Get 1,000 subsidiaries free

Explore Corporate Structures Worldwide

Astellas Pharma’s ownership network is part of more than 41 million corporate hierarchies mapped in our company ownership database. It shows how companies are connected globally, detailing parent companies and subsidiaries with verified data from businesses in 200 countries and jurisdictions. See how our dataset works — and request a custom sample.

Astellas Pharma Company Facts

Where is Astellas Pharma headquartered?

In Tokyo, Japan.

How many subsidiaries does Astellas Pharma have?

Astellas Pharma owns many subsidiaries across major markets including the USA, Europe, and Asia.

Who owns Astellas Pharma?

Astellas Pharma Inc. is publicly listed; ownership is distributed among various shareholders.

Is Astellas Pharma a Japanese company?

Yes. Astellas Pharma is incorporated in Japan with headquarters in Tokyo.

How many employees work for Astellas Pharma?

Astellas Pharma employs tens of thousands of people worldwide.

Corporate family tree

Understanding Astellas Pharma’s Ownership and Structure

Knowing who owns and controls a company reveals how it operates worldwide. Our corporate hierarchy data helps you track how Astellas Pharma connects with its subsidiaries and parent companies, showing control, structure, and operational reach. Whether for compliance, market research, or better CRM management, understanding Astellas Pharma’s structure brings clarity. CompanyData.com stores verified ownership records from millions of companies globally to give you a clear picture of corporate networks and influence across industries and countries.

How We Track Astellas Pharma’s Worldwide Headquarters and Subsidiaries

CompanyData.com uses a clear three-level approach to map Astellas Pharma’s global corporate structure: Global, National, and Local headquarters. This captures how the company’s entities fit together and operate in various markets.

The three-level hierarchy explained

  • Global Headquarter — Astellas Pharma Inc. is the global headquarters, overseeing all worldwide operations and subsidiaries. This is the highest controlling entity in the group.
  • National Headquarters — Country-specific companies like Astellas Pharma Germany GmbH, Astellas Pharma France SAS, and Astellas Pharma USA Inc. manage operations locally and report back to the global parent.
  • Local Headquarters — Regional or market-focused subsidiaries manage specific manufacturing sites, sales offices, or business units within countries, maintaining compliance and operational control locally.

Each company entity has a unique identifier in our system, so you can connect subsidiaries to their parent groups and visualize ownership and control structures clearly.

Ownership and control explained

Control is based on ownership percentage. When a company holds more than 50% of another’s shares, it is classified as a controlled subsidiary. Our data focuses on these majority ownership links to clearly map Astellas Pharma’s complex global structure. This transparency helps users understand who really governs operations within the group.

Why this mapping is important

This model highlights the key decision makers inside Astellas Pharma, simplifying risk and compliance reviews while supporting market research and mergers and acquisitions. With verified data on more than 41 million companies globally, covering 200 countries, CompanyData.com provides a clear and trusted view of Astellas Pharma’s worldwide corporate structure.

 

Astellas Pharma

Who This Solution Is For

CompanyData.com supports global organizations that need verified insights into corporate ownership structures, from CRM enrichment and compliance workflows to market intelligence and analytics. We provide free evaluation samples; larger data samples (for example, up to 1,000 companies) are available to qualified corporate buyers with a defined use case and an active company website. If your primary need is contact or lead lists, please visit our Company Data Platform instead.

  • Tell us about your use case or data requirements
  • Samples are available to officially registered companies with an active website
  • Files delivered in CSV or Excel format
  • API integrations available

Get Your Free Quote

Share your use case or data challenge, and our team will provide a tailored ownership data sample within 24 hours.

"*" indicates required fields

Tell us how you'll leverage our data for your data-driven project.
85 reviews

Astellas Pharma global structure & subsidiary overview

Astellas Pharma Inc. is a global pharmaceutical company with total revenue of $11.84 billion. Headquartered in Tokyo, Japan, Astellas Pharma focuses on developing and delivering innovative medicines for various therapeutic areas. The company has a wide global footprint with subsidiaries and affiliates operating in countries worldwide, helping it to reach patients and healthcare providers across many regions.

Astellas Pharma’s Business Focus:

Astellas Pharma works mainly in research and development of treatments for oncology, urology, immunology, and neuroscience. Their goal is to improve patient outcomes through cutting-edge therapies and strong partnerships.

Global Presence and Subsidiaries:

Astellas has subsidiaries in many countries, including significant operations in the United States, Europe, and Asia. Their global corporate structure helps manage regulatory requirements and adapt to local market needs effectively. You can explore [Astellas Pharma company data in the USA](https://companydata.com/usa-company-data/), [in Europe](https://companydata.com/company-data-europe/), or specific countries such as [France](https://companydata.com/france-company-data/) and [Germany](https://companydata.com/german-company-data/).

Financial Highlights:

With $11.84 billion in revenue, Astellas Pharma has maintained steady growth through innovation and acquisitions. The company invests heavily in R&D to support its product pipeline and long-term strategy.

Corporate Responsibility:

Astellas is committed to ethical business practices and contributing to global health through sustainable initiatives. They follow strict regulatory standards and aim to increase access to medicines worldwide.

Challenges and Opportunities:

Like many pharmaceutical companies, Astellas faces challenges in drug development timelines and market competition. However, its diverse portfolio and global subsidiaries position it well for continued success.

Summary:

Astellas Pharma is a major player in the global pharmaceutical industry with a strong focus on innovation and worldwide subsidiaries supporting its operations. For the latest detailed company data and subsidiary information, please visit trusted sources or contact us for a tailored dataset.

 

 

You can access comprehensive Astellas Pharma company data through CompanyData.com via API, Excel files, or bulk download. We prepare custom datasets based on your industry or geographic preferences, including subsidiary details and financial data. After submitting your requirements, we provide a free quote and sample data within 24 hours. Once confirmed, you receive your data quickly in your chosen format.

Yes, CompanyData.com offers complete global datasets for many pharmaceutical and healthcare companies worldwide. Whether you want data for a specific region or sector like biotech or medical devices, we tailor the dataset to meet your needs. Contact us to receive a free quote and sample data within one day.

The $11.84 billion revenue number represents the total income Astellas Pharma generated from sales of pharmaceutical products and related services globally. This figure helps show the company’s market scale and financial performance within the pharmaceutical industry.

Astellas Pharma has key subsidiaries mainly in the USA, [Europe](https://companydata.com/company-data-europe/), and Asia-Pacific regions. Specific countries with notable subsidiaries include the United States, Japan, France, Germany, the United Kingdom, and Australia. These subsidiaries help manage local operations and regulatory compliance.

Our data is collected from verified official sources including company filings, regulatory records, and trusted global business registries. This ensures that information about companies like Astellas Pharma is accurate, up-to-date, and compliant with data protection laws.

Get a Free Quote and Sample

Tell us your target group, and we’ll send you a free quote and a tailored company ownership dataset — sample included. Call +31 20 705 236 or email sales@companydata.com. Ready to order? Simply reply to the quote, and CompanyData.com delivers your dataset in CSV or Excel within 24 hours.

You’ll be in good company

Discover more Top Companies

3i Group 3M A2A AB InBev ABB Abu Dhabi Islamic Bank Accenture Acciona Adani Enterprises Adecco Adidas Adobe ADP Advance Auto Parts Advanced Micro Devices AECOM Technology Aegon Aena AGCO Corporation Ageas Agilent Technologies Agility Ahold Delhaize Air France-KLM Air Liquide Airbus Ajinomoto Akzo Nobel Albertsons Alcon Alibaba Group Allianz Allstate Alpha Bank Alphabet Inc Alstom Altice USA Amazon Amcor Amerco América Móvil American Airlines American Tower Ameriprise Financial Ametek Amphenol Analog Devices Anglo American Aon Apollo Global Management Apple Applied Materials Aptiv Aramark Aramco ArcelorMittal Archer Daniels Midland Arkema Arrow Electronics Asahi Group Holdings Asahi Kasei Asian Paints ASML Holding Assa Abloy Astellas Pharma AstraZeneca AT&T Atlas Copco Atlassian Autodesk AutoNation AutoZone AXA BAIC Motor Baidu Baker Hughes Bank of America Bank of Baroda Bank of China Bank of Montreal Bank of Tianjin Bankinter Barclays Barrick Gold BASF Bausch Health Companies Baxter Bayer BBVA Becton Dickinson Beiersdorf AG Berkshire Hathaway Best Buy BHP BlackRock Blackstone Block Inc., Bluescope Steel BMW BNP Paribas Boeing Booking Holdings BorgWarner Boston Scientific Bouygues BP Brenntag Bridgestone Bristol Myers Squibb British American Tobacco Broadcom Brookfield Asset Management Brown-Forman BT Group Builders FirstSource Bunge Bunzl BYD Campbell Soup Canadian Tire Canara Bank Canon Capgemini Capital One Cardinal Health Carnival Corporation Carrefour Carrier Global CBRE CDW Corporation Celanese Cellnex Telecom Cemex Centene Centrica CGI Charoen Pokphand Foods Charter Communications Chevron Corporation China Mobile Chipotle Mexican Grill Chow Tai Fook Jewellery Chubb Cisco Citigroup CME Group
CMS Energy CNH Industrial CNPC Capital Coca-Cola Cognizant Colgate-Palmolive Comcast Corporation Comerica Commercial Bank of Qatar Commerzbank Compal Electronics Compass Group Conagra Brands Concordia Financial Group ConocoPhillips Constellation Brands Continental Corteva Cosco Shipping Costco Wholesale Covestro CRH CrowdStrike CSC Financial CSL CSX Cummins Dai-ichi Life Daiichi Sankyo Daikin Daimler Truck Danaher Danone Danske Bank Darden Restaurants Dell Delta Air Lines Delta Electronics Denso Dentsu Deutsche Bank Deutsche Lufthansa Deutsche Telekom DexCom Diageo Dollar General Dollar Tree Doosan Dover Dow DSV DuPont DXC Technology E.ON Eaton eBay Ecolab Electronic Arts Elevance Health Eli Lilly Emaar Properties Emera Emerson Electric Empire Company Limited Enbridge EnBW Enel ENEOS Holdings ENGIE Eni ENN Natural Gas Entergy EQT Equitable Holdings Ericsson EssilorLuxottica Essity Estee Lauder Companies Eurofins Scientific Societe Europeenne Exelon Corporation Expedia Group Expeditors International Experian ExxonMobil Facebook Falabella FedEx Femsa Ferrari Ferrovial FirstRand Fiserv Flex Ltd Flutter Entertainment FMC Ford Fortive Fox Corporation Freeport-McMoRan Fresenius Fujifilm Holdings Fujitsu Garmin Gazprom General Dynamics General Electric General Mills General Motors Genuine Parts Company Gilead Sciences Glencore Global Payments Goertek Inc. Goodman Group Goodyear Tire & Rubber Company Google Grupo Bimbo GSK Guotai Junan Securities Haier Halliburton Halyk Bank Hanwha HCA Healthcare HCL Technologies HDFC Bank Henkel Hess Corporation Hewlett Packard Enterprise Hewlett-Packard Hexagon AB Hikvision Hitachi HNA Technology Hoa Phat Group Hokuhoku Financial Group Holcim Hologic Hon Hai Precision Honda Honeywell Hong Leong Financial HOYA Corporation HSBC Huntington Bank Hyundai
Iberdrola ICICI Bank Illinois Tool Works Illumina Imperial Brands Infosys Ingersoll Rand Inpex Intel Intercontinental Exchange Intesa Sanpaolo Intuit Invesco Investec IQVIA Itochu Jardine Matheson Jefferies John Deere Johnson Controls International JPMorgan Chase Kakao Kellogg Kering Keurig Dr Pepper Keysight Technologies KIA Kimberly-Clark Kingspan Group Kohl’s Corporation Kohlberg Kravis Roberts Kone Koninklijke KPN N.V. Kraft Heinz Company Kroger Kuwait Finance House L3Harris LabCorp Las Vegas Sands Legrand Lenovo Leonardo LG Liberty Global Liberty Media Corporation List of Top 2000 Companies Live Nation Entertainment Lockheed Martin Louis Vuitton LukOil LyondellBasell Industries M&G Macquarie Group Macy’s Magna International Manulife Marriott International Marsh McLennan Martin Marietta Materials Marubeni Mastercard Mazda Motor McDonald’s McKesson Mediobanca Medipal Holdings Medtronic Mercedes-Benz Group MetLife Michelin Micron Technology Microsoft Mitsubishi Mitsui & Co. Mizuho Financial Group Molson Coors Mondelez International Monster Beverage Morgan Stanley Motorola Solutions NASDAQ National Grid NatWest Group Nestlé Netflix New Hope Liuhe Newmont NextEra Energy Nidec Nintendo Nissan Motor Nokia Nomura Holdings Northern Trust Northrop Grumman Novartis Novo Nordisk NRG Energy Nucor Nvidia NVR, Inc. NXP Semiconductors Occidental Petroleum Old Mutual Omnicom Group Oracle Organon Orix Owens Corning Paccar Palo Alto Networks Panasonic Paramount Parker-Hannifin PayPal PBF Energy Pegatron Pernod Ricard Petronas Chemicals Philip Morris International Philips PNC Poste Italiane PPG Principal Financial Group Procter & Gamble Progressive Prudential Publicis Groupe Punjab National Bank Qualcomm Quanta Services Raiffeisen Bank International Rakuten Raymond James Raytheon Technologies Reckitt Reinsurance Group of America Reliance Industries Limited Renault Repsol Restaurant Brands International Rexel Richemont Rio Tinto Rocket Companies
Rockwell Automation Rogers Communications Rolls-Royce Holdings Rosneft Royal Bank of Canada Royal Caribbean Group S&P Global Safran Salesforce Samhallsbyggnadsbolaget I Norden Samsung Sandvik Sanofi Santander SAP SBI Holdings Schindler Holding Schlumberger Schneider Electric Schroders Scotiabank Sempra Seven & I Holdings Shell Company Profile Sherwin-Williams Shinsei Bank Sibanye Stillwater Siemens SK Hynix SM Investments Snap Societe Generale Sodexo SoftBank Group Sony Southwest Airlines SS&C Technologies Standard Chartered Stanley Black & Decker Starbucks State Street Stellantis Sumitomo Sun Pharma Industries Suzuki Motor Swatch Group Swiss Re Synopsys Taiwan Semiconductor Targa Resources Target Tata Motors Tata Steel Tatneft TBEA TC Energy TCL TD Bank Group TD Synnex Corporation TE Connectivity Tech Mahindra Techtronic Industries Telefónica Teleperformance Telstra TELUS Tencent Holdings Tenet Healthcare Tesco Tesla Teva Pharmaceutical Texas Instruments Textron Inc. Thales The Hartford The Walt Disney Company Thomson Reuters ThyssenKrupp Group TJX Companies Tokio Marine Holdings Tongwei Toshiba TotalEnergies Toyota TransDigm Group Transneft Transurban Group Twitter Tyson Foods UBS UniCredit Unilever United Parcel Service US Bancorp US Foods Usiminas Veolia Environnement Verizon Vestas Viatris VINCI Virgin Money UK Visa Inc Vivendi Vodafone Volkswagen Volvo Group Wabtec Corporation Walgreens Walmart Warner Bros. Discovery Welltower Wens Foodstuff Group Wesfarmers West Fraser Timber Co. West Japan Railway Company West Pharmaceutical Services Western Alliance Bancorp Western Digital Westlake Chemical Westpac Whirlpool Willis Towers Watson Wilmar International Wipro Wolters Kluwer Woodside Energy Woolworths Woori Financial Group Workday World Fuel Services WPG Holdings WPP Wuxi Apptec Xiaomi Yamaha Motor Yum Brands Yum China Holdings Zalando Zimmer Biomet Zoom Video Communications Zoomlion Heavy Industry ZTE Corporation Zurich Insurance Group
Request sample Try 10 Contacts Free
Call
+31(0)20 705 2360